Cardinal Health "outperform"

06/15/07 - Robert W. Baird

NEW YORK, June 15 (newratings.com) - Analysts at Robert W Baird maintain their "outperform" rating on Cardinal Health Inc (CAH). The target price is set to $86.

In a research note published this morning, the analysts mention that Cardinal Health and Eli Lilly have publicly discussed the initial distributor/supplier success from the Six Sigma initiatives. As a result of the Six Sigma initiatives, Cardinal Health and Eli Lilly’s inventory claims have declined by 90%, and the claim entry lead times declined to nine days, the analysts add. Eli Lilly indicates that as a result of these initiatives, both the companies have become better trading partners, Robert W Baird says.